PMC:7228307 / 44531-44621 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"803","span":{"begin":11,"end":15},"obj":"Gene"},{"id":"823","span":{"begin":52,"end":70},"obj":"Disease"},{"id":"844","span":{"begin":23,"end":28},"obj":"Mutation"}],"attributes":[{"id":"A803","pred":"tao:has_database_id","subj":"803","obj":"Gene:5133"},{"id":"A823","pred":"tao:has_database_id","subj":"823","obj":"MESH:D003141"},{"id":"A844","pred":"tao:has_standard_notation","subj":"844","obj":"rs1469294455"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Nivolumab PD‐1 IgG4 S228P Stabilize core hinge Infectious disease; oncology Marketed"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T74","span":{"begin":52,"end":70},"obj":"Disease"}],"attributes":[{"id":"A74","pred":"mondo_id","subj":"T74","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Nivolumab PD‐1 IgG4 S228P Stabilize core hinge Infectious disease; oncology Marketed"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T227","span":{"begin":11,"end":13},"obj":"Chemical"}],"attributes":[{"id":"A227","pred":"chebi_id","subj":"T227","obj":"http://purl.obolibrary.org/obo/CHEBI_74756"}],"text":"Nivolumab PD‐1 IgG4 S228P Stabilize core hinge Infectious disease; oncology Marketed"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T216","span":{"begin":52,"end":70},"obj":"http://purl.obolibrary.org/obo/IDO_0000436"},{"id":"T217","span":{"begin":63,"end":70},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"}],"text":"Nivolumab PD‐1 IgG4 S228P Stabilize core hinge Infectious disease; oncology Marketed"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"803","span":{"begin":11,"end":15},"obj":"Gene"},{"id":"823","span":{"begin":52,"end":70},"obj":"Disease"},{"id":"844","span":{"begin":23,"end":28},"obj":"Mutation"}],"attributes":[{"id":"A803","pred":"pubann:denotes","subj":"803","obj":"Gene:5133"},{"id":"A823","pred":"pubann:denotes","subj":"823","obj":"MESH:D003141"},{"id":"A844","pred":"pubann:has_HGVS_notation","subj":"844","obj":"rs1469294455"}],"text":"Nivolumab PD‐1 IgG4 S228P Stabilize core hinge Infectious disease; oncology Marketed"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T255","span":{"begin":0,"end":90},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Nivolumab PD‐1 IgG4 S228P Stabilize core hinge Infectious disease; oncology Marketed"}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T523","span":{"begin":11,"end":15},"obj":"Protein"}],"attributes":[{"id":"A523","pred":"uniprot_id","subj":"T523","obj":"https://www.uniprot.org/uniprot/Q7M4M5"},{"id":"A524","pred":"uniprot_id","subj":"T523","obj":"https://www.uniprot.org/uniprot/Q6NZ54"},{"id":"A525","pred":"uniprot_id","subj":"T523","obj":"https://www.uniprot.org/uniprot/Q3KQW2"},{"id":"A526","pred":"uniprot_id","subj":"T523","obj":"https://www.uniprot.org/uniprot/P18621"},{"id":"A527","pred":"uniprot_id","subj":"T523","obj":"https://www.uniprot.org/uniprot/J3QL51"},{"id":"A528","pred":"uniprot_id","subj":"T523","obj":"https://www.uniprot.org/uniprot/B5ME31"},{"id":"A529","pred":"uniprot_id","subj":"T523","obj":"https://www.uniprot.org/uniprot/B4E3C2"},{"id":"A530","pred":"uniprot_id","subj":"T523","obj":"https://www.uniprot.org/uniprot/B2R4H3"}],"text":"Nivolumab PD‐1 IgG4 S228P Stabilize core hinge Infectious disease; oncology Marketed"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T30","span":{"begin":52,"end":70},"obj":"Disease"}],"attributes":[{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Nivolumab PD‐1 IgG4 S228P Stabilize core hinge Infectious disease; oncology Marketed"}

{"project":"LitCovid-sample-PD-HP","denotations":[{"id":"T24","span":{"begin":72,"end":80},"obj":"Phenotype"}],"attributes":[{"id":"A24","pred":"hp_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"Nivolumab PD‐1 IgG4 S228P Stabilize core hinge Infectious disease; oncology Marketed"}

{"project":"LitCovid-sentences","denotations":[{"id":"T255","span":{"begin":0,"end":90},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Nivolumab PD‐1 IgG4 S228P Stabilize core hinge Infectious disease; oncology Marketed"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T24","span":{"begin":72,"end":80},"obj":"Phenotype"}],"attributes":[{"id":"A24","pred":"hp_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"Nivolumab PD‐1 IgG4 S228P Stabilize core hinge Infectious disease; oncology Marketed"}